Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Vtrs Stock Analysis Viatris Inc. Pharma Stock Falls 1.39 To 13.44 Key Support In Focus 20260403 Is Tantech Tanh Stock Better Than Industry Peers Price At 0.38 Up 2.91 20260410 Is NXG SRV stock a smart buy at current levels Slight Dip 20260418 LGI Homes LGIH Stock Imputed Dividend Investors Pile In 20260418 What would it take for HUTCHMED HCM to double from here Mini Selloff 20260508 Live LYV Stock Is It Undervalued vs Peers Momentum Fading 20260418 Is Everspin Technologies MRAM stock in consolidation Buying Pressure 20260418 Hudson HPP Down 391 How Low Could It Go 20260515 Adani Group Agrees to 18 Million Settlement in US Civil Fraud Case Fed Governor Miran Resigns Endorses Kevin Warsh as Next Chair SafeHaven Demand Lifts Swiss Franc and Japanese Yen as DeepSeek AI News Shakes Tech Stocks Ryder System R Delivers Q1 2026 Beat EPS 254 vs 232 Expected Should You Sell Navitas NVTS After 461 Drop 20260515 BOJ May Slow Bond Taper as Market Turbulence Rattles Investors Kinross KGC Stock Slides 144 Support at 2928 20260514 Carpenter CRS Q1 2026 Earnings EPS 277 Beats Estimates Should You Sell SK Telecom SKM After 109 Drop 20260517 FTAIM Q1 2026 Earnings Preferred Shares Hold Steady as EPS Misses Estimates MGM MGM Q1 2026 Results Miss Estimates EPS 049 vs 054 CG Oncology CGON Stock Slides 108 Support Test Looms at 6086 20260521 Gland Pharma Surges to 52Week High on Cenexi Turnaround Capacity Expansion and New Product Pipeline Helmerich HP Q1 2026 Earnings Miss EPS 038 vs 002 Expected Healthcare and Tech Lead SP 500 to Modest Gains NetEase Stock Declines Following Q1 Earnings Beat Market Reacts to Mixed Signals Evolution Petroleum EPM Q1 2026 Earnings Massive EPS Miss Sends Shares Lower Coterra Energy Q4 2025 Earnings EPS Misses Estimates as Commodity Headwinds Pressure Results HMR Q4 2025 Earnings Heavy EPS Miss Despite Stock Surge JBDI Holdings JBDI Drops 17 Support Level Tested Near 040 ASND Q1 2026 Earnings Wide EPS Miss as Ascendis Pharma Remains PreRevenue Stock Edges Higher SWKS Q1 2026 Earnings Strong EPS Beat Drives DoubleDigit Stock Surge CCB Q1 2026 Earnings EPS Falls Short as Profitability Pressures Mount BioXcel Therapeutics BTAI Q1 2026 Earnings EPS Misses Expectations as PreRevenue Biotech Focuses on Pipeline Progress Extreme Networks EXTR Q1 2026 Earnings EPS Beat Drives 745 Stock Rally FBIO Q4 2025 Earnings Significant EPS Surprise Miss Amid Limited Revenue Disclosure